Results 171 to 180 of about 272,304 (250)

Magnetic Micro‐ and Nanorobots for Precision Thrombolysis: Design Strategies and Translational Challenges

Advanced Robotics Research, EarlyView.
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin, Yimo Yan, Nikola Cesarovic, Simone Schuerle   +3 more
wiley   +1 more source

Development and patterns of acute-on-chronic liver failure in patients with cirrhosis and acute kidney injury. [PDF]

JHEP Rep
Fischer S, McCoy MS, Fiocco M, Kerbert A, Cervantes-Alvarez E, Hähner J, Praktiknjo M, Brol MJ, Uschner FE, Wolters L, Zeuzem S, Cabello J, Peiffer KH, Balak J, Arbous S, Nieuwenhuizen J, van Westerloo D, Jan van Zonneveld A, Trebicka J, Coenraad M.   +19 more
europepmc   +1 more source

Strategic Design of Soft Actuators in Translational Medical Robotics for Human‐Centered Healthcare

Advanced Robotics Research, EarlyView.
Soft robotics enables biocompatible, compliant medical devices, but clinical translation requires design‐driven engineering beyond materials. This perspective reviews implantable, surgical, and wearable systems by actuation mechanism, highlighting how optimized architectures and integration improve mechanical interfacing, adaptability, and durability ...
Ho Jun Jin, Jimin Kim, Inho Kim, Bong Hoon Kim   +3 more
wiley   +1 more source

Higher prevalence of cytomegalovirus and Epstein-Barr virus in acute-on-chronic liver failure. [PDF]

JHEP Rep
Thiyagarajah K, Sonnenberg J, Görgülü E, Lembeck P, Kraus N, Glitscher M, Uschner FE, Brol MJ, Gu W, Schierwagen R, Klein S, McCoy MS, Mücke MM, Wiedemann T, Reuken PA, Reißing J, Schneider F, Böhling N, Praktiknjo M, Tepasse PR, Fischer J, Zeuzem S, Welsch C, Ciesek S, Stallmach A, Trebicka J, Chang J, Bruns T, Hildt E, Peiffer KH.   +29 more
europepmc   +1 more source

Dual Role of Tamoxifen in Enhancing STING and CEACAM1 Expression to Prime a Favorable Tumor Microenvironment for Anti‐TIM3 Immunotherapy

Advanced Science, EarlyView.
Anti‐PD‐1/PD‐L1 blockade has revolutionized cancer immunotherapy, but is ineffective against endocrine‐treated (i.e., Tamoxifen), relapsed ER+ breast cancer (BC) patients. This study provides insight into the sub‐optimal response of ER+BCs to anti‐PD‐1/PD‐L1 blockade – highlighting the induction of STING and the CEACAM1/TIM3 axis after chronic ...
Marvin Angelo E Aberin, Saurabh Singh, Soumya Chatterjee, Guang‐Zhi Sui, Yi‐Fu Wang, Ya‐Ting Lu, Yu‐Ling Lee, Kun‐Yuan Lin, Joy Khag, Ta‐Yu Liu, Shao‐Han Chang, Wai‐Mui Cheung, Hsiao‐Chin Hong, Ren‐Jun Hsu, Chen‐Yang Shen, Chia‐Wei Li, Weng‐Lang Yang, Yao‐Ming Chang, Shih‐Yu Chen, Chandan Guha, Shu‐Ping Wang   +20 more
wiley   +1 more source

Acute-on-Chronic Liver Failure in a 13-Year-Old Patient With Wilson's Disease Due to Dengue Virus Infection: A Case Report. [PDF]

Cureus
Balmaceda Araya E, Murillo González M, Osawa Pivovarov A, Robles Ruiz J, Taylor Roldán I.   +4 more
europepmc   +1 more source

Agnuside Stabilizes the Complex I Assembly Factor NDUFAF6 to Reinforce Mitochondrial Efficiency and Thermogenic Responsiveness

Advanced Science, EarlyView.
ABSTRACT Brown and beige adipocytes dissipate energy as heat, yet effective strategies to enhance their mitochondrial efficiency remain limited. Here, we identify Agnuside (AGN) as a selective stabilizer of the complex I assembly factor NDUFAF6. AGN directly binds cytosolic NDUFAF6, suppresses its ubiquitination, prolongs its half‐life, and facilitates
Qingwen Zhao, Li Xie, Qianzhuo Wang, Shuying Dai, Bei Li, Yingjuan Zhang, Zhe Sun, Yue Gao   +7 more
wiley   +1 more source

Impact of Underlying Portal Hypertension on Severity and Course of Acute-On-Chronic Liver Failure. [PDF]

Liver Int
Taru V, Kramer G, Hofer BS, Dominik N, Balcar L, Schneeweiss-Gleixner M, Procopet B, Trauner M, Mandorfer M, Schwabl P, Reiberger T, Simbrunner B.   +11 more
europepmc   +1 more source

Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner

Advanced Science, EarlyView.
Canagliflozin treatment reshapes the gut microbiota in DKD and elevates levels of melibiose, a metabolite derived from Roseburia intestinalis. Melibiose directly binds to and enhances the enzymatic activity of glyoxalase 1, leading to decreased methylglyoxal accumulation.
Wei Zhang, Yi Song, Changkun Li, Yuanyuan Luo, Mingwei Shao, Feng Guo, Fangyi Wei, Xunjie Fan, Wenwen Guo, Fengmei Xu, Yanhong Sang, Dongming Zhang, Yanhong Zhou, Lianwei Wang, Zhiqiang Kang, Yingjun Yang, Chunhua Song, Yanxia Liu, Xiaojun Ma, Jiao Wang, Chong Li, Shengnan Ma, Lin Zhao, Zhi Qin, Guolan Xing, Qiubo Zhao, Jun Li, Shumin Song, Dan Zhao, Ting Huang, Qingzhu Wang, Yanyan Zhao, Guijun Qin   +32 more
wiley   +1 more source

The attenuated incretin effect is associated with glucose intolerance in patients with hepatitis B-related acute-on-chronic liver failure. [PDF]

Front Physiol
Li M, Hu H, Liu Y, Wu X, Zhang Y, Li Y, Yang F, Li Y, Lin S.   +8 more
europepmc   +1 more source